======= EIF4B ======= == Gene Information == * **Official Symbol**: EIF4B * **Official Name**: eukaryotic translation initiation factor 4B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1975|1975]] * **UniProt**: [[https://www.uniprot.org/uniprot/P23588|P23588]] * **Interactions**: [[https://thebiogrid.org/search.php?search=EIF4B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EIF4B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603928|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Required for the binding of mRNA to ribosomes. Functions in close association with EIF4-F and EIF4-A. Binds near the 5'- terminal cap of mRNA in presence of EIF-4F and ATP. Promotes the ATPase activity and the ATP-dependent RNA unwinding activity of both EIF4-A and EIF4-F. |RRM 1| |RNA strand-exchange activity| |eukaryotic translation initiation factor 4F complex assembly| |RNA strand annealing activity| |formation of translation preinitiation complex| |eukaryotic translation initiation factor 4F complex| |ribosomal small subunit binding| |cytoplasmic translational initiation| |polysome| |translation initiation factor activity| |cytoplasmic translation| |regulation of translational initiation| |translational initiation| |ribonucleoprotein complex assembly| |ribonucleoprotein complex subunit organization| |regulation of translation| |translation| |regulation of cellular amide metabolic process| |peptide biosynthetic process| |ribonucleoprotein complex biogenesis| |posttranscriptional regulation of gene expression| |amide biosynthetic process| |peptide metabolic process| |cellular amide metabolic process| |cellular protein-containing complex assembly| |RNA binding| |organonitrogen compound biosynthetic process| |protein-containing complex assembly| |cellular nitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |protein-containing complex subunit organization| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp451|Atovaquone 15μM R08 exp451]]|-2.68| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-2| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.74| |[[:results:exp314|Dimethyloxaloylglycine 11μM R07 exp314]]|1.72| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|1.72| |[[:results:exp90|WYE-354 6μM R02 exp90]]|1.74| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|1.77| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|1.8| |[[:results:exp362|GSK-J4 1μM R07 exp362]]|1.8| |[[:results:exp210|LB-100 2μM R05 exp210]]|1.8| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|1.81| |[[:results:exp18|Doxycycline 10μM R00 exp18]]|1.83| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.87| |[[:results:exp423|Zebularine 20μM R07 exp423]]|1.89| |[[:results:exp485|GSK626616 14μM R08 exp485]]|1.94| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|1.96| |[[:results:exp331|A-769662 20μM R07 exp331]]|1.99| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|2.05| |[[:results:exp492|iCRT14 30μM R08 exp492]]|2.06| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|2.06| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|2.07| |[[:results:exp512|Olaparib 4μM R08 exp512]]|2.08| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.11| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|2.23| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|2.3| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|2.35| |[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|3.03| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|3.05| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|3.1| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|3.77| ^Gene^Correlation^ |[[:human genes:d:ddx3x|DDX3X]]|0.494| |[[:human genes:z:znf148|ZNF148]]|0.456| |[[:human genes:c:cdk8|CDK8]]|0.455| |[[:human genes:e:eif4h|EIF4H]]|0.428| |[[:human genes:t:tsc2|TSC2]]|0.425| |[[:human genes:e:eif2ak4|EIF2AK4]]|0.423| |[[:human genes:m:msi2|MSI2]]|0.423| |[[:human genes:g:golga6l1|GOLGA6L1]]|0.423| |[[:human genes:e:eif3g|EIF3G]]|0.419| |[[:human genes:e:eif3a|EIF3A]]|0.417| |[[:human genes:r:rps12|RPS12]]|0.408| |[[:human genes:a:arid4b|ARID4B]]|0.407| Global Fraction of Cell Lines Where Essential: 46/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|2/28| |blood|2/28| |bone|5/26| |breast|3/33| |central nervous system|2/56| |cervix|0/4| |colorectal|1/17| |esophagus|1/13| |fibroblast|0/1| |gastric|2/16| |kidney|0/21| |liver|0/20| |lung|4/75| |lymphocyte|4/16| |ovary|3/26| |pancreas|1/24| |peripheral nervous system|1/16| |plasma cell|1/15| |prostate|0/1| |skin|2/24| |soft tissue|1/9| |thyroid|0/2| |upper aerodigestive|1/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12399 * **Expression level (log2 read counts)**: 9.14 {{:chemogenomics:nalm6 dist.png?nolink |}}